Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes
US7632647B2 · kind B2 · utility
12Cited by
33References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 13, 2001 |
| Grant date | Dec 15, 2009 |
| Priority date | — |
| Expiry date | Feb 1, 2026 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/324
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to materials and procedures for evaluating the prognosis of patients suffering from acute coronary syndromes. In particular, the level of BNP, or a marker related to BNP, in a patient sample, alone or in combination with one or more other prognostic markers, provides prognostic information useful for predicting near-term morbidity and/or mortality across the entire spectrum of acute coronary syndromes, including unstable angina, non-ST-elevation non-Q wave myocardial infarction, ST-elevation non-Q wave MI, and transmural (Q-wave) MI.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.